Filing Details

Accession Number:
0001708138-20-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-03 16:08:14
Reporting Period:
2020-04-01
Accepted Time:
2020-04-03 16:08:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238303 J Joseph Larosa 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp General Counsel And Secret No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-01 5,000 $59.20 19,438 No 4 M Direct
Common Stock Disposition 2020-04-01 2,757 $488.22 16,681 No 4 F Direct
Common Stock Acquisiton 2020-04-01 5,000 $59.20 21,681 No 4 M Direct
Common Stock Disposition 2020-04-01 2,757 $488.22 18,924 No 4 F Direct
Common Stock Acquisiton 2020-04-01 5,000 $59.20 23,924 No 4 M Direct
Common Stock Disposition 2020-04-01 2,689 $488.22 21,235 No 4 F Direct
Common Stock Disposition 2020-04-02 192 $484.58 21,043 No 4 S Direct
Common Stock Disposition 2020-04-02 441 $485.65 20,602 No 4 S Direct
Common Stock Disposition 2020-04-02 485 $486.61 20,117 No 4 S Direct
Common Stock Disposition 2020-04-02 470 $487.71 19,647 No 4 S Direct
Common Stock Disposition 2020-04-02 1,626 $488.26 18,021 No 4 S Direct
Common Stock Disposition 2020-04-02 734 $489.72 17,287 No 4 S Direct
Common Stock Disposition 2020-04-02 484 $490.32 16,803 No 4 S Direct
Common Stock Disposition 2020-04-02 450 $491.42 16,353 No 4 S Direct
Common Stock Disposition 2020-04-02 521 $492.62 15,832 No 4 S Direct
Common Stock Disposition 2020-04-02 652 $493.35 15,180 No 4 S Direct
Common Stock Disposition 2020-04-02 111 $494.36 15,069 No 4 S Direct
Common Stock Disposition 2020-04-02 321 $495.19 14,748 No 4 S Direct
Common Stock Disposition 2020-04-02 210 $496.50 14,538 No 4 S Direct
Common Stock Disposition 2020-04-02 100 $497.32 14,438 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-04-01 5,000 $0.00 5,000 $59.20
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-04-01 5,000 $0.00 5,000 $59.20
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-04-01 5,000 $0.00 5,000 $59.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
49,933 2021-09-01 No 4 M Direct
44,933 2021-09-01 No 4 M Direct
39,933 2021-09-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 255 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 192 shares of Company stock on April 2, 2020 at prices ranging from $484.12 to $484.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 441 shares of Company stock on April 2, 2020 at prices ranging from $485.01 to $485.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 485 shares of Company stock on April 2, 2020 at prices ranging from $486.15 to $486.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 470 shares of Company stock on April 2, 2020 at prices ranging from $487.32 to $487.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  6. Represents volume-weighted average price of sales of 1,626 shares of Company stock on April 2, 2020 at prices ranging from $488.00 to $488.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  7. Represents volume-weighted average price of sales of 734 shares of Company stock on April 2, 2020 at prices ranging from $489.31 to $489.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  8. Represents volume-weighted average price of sales of 484 shares of Company stock on April 2, 2020 at prices ranging from $490.11 to $490.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  9. Represents volume-weighted average price of sales of 450 shares of Company stock on April 2, 2020 at prices ranging from $491.13 to $491.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  10. Represents volume-weighted average price of sales of 521 shares of Company stock on April 2, 2020 at prices ranging from $492.22 to $492.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  11. Represents volume-weighted average price of sales of 652 shares of Company stock on April 2, 2020 at prices ranging from $493.01 to $493.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  12. Represents volume-weighted average price of sales of 111 shares of Company stock on April 2, 2020 at prices ranging from $494.29 to $494.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  13. Represents volume-weighted average price of sales of 321 shares of Company stock on April 2, 2020 at prices ranging from $495.09 to $495.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  14. Represents volume-weighted average price of sales of 210 shares of Company stock on April 2, 2020 at prices ranging from $496.37 to $496.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  15. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.